Baxter’s future vision: focus only on medical products

Baxterplans to focus on rolling out 50 new medical devices worth more than USD 1 billion in annual sales by 2020, with an additional compounded annual sales growth of 4%. If Baxter rolls out these new products, their sales contributions will represent 10% of its total revenues in 2020 and more than 20% by 2025.The company will also embark on acquisitions and collaborations to expand its product portfolio, but none of the acquisitions will be as great as the USD 4 billion Gambro acquisition, which contributed toward structuringits foundation. Baxter presumes to disburse more than 10% of sales on research and development by 2020 for development of life cycle management products and some novel products along with strengthening of its proficiency in drug delivery systems.

(Image Courtesy: Baxter)
Read the full article at FierceMedicalDevices